Cart
sales@molnova.com
BCIP
CAS No. 6578-06-9
BCIP( BCIP p-toluidine salt | X-phosphate p-toluidine salt )
Catalog No. M27033 CAS No. 6578-06-9
BCIP (BCIP p-toluidine salt) is an artificial chromogenic substrate. It is used for the sensitive colorimetric detection of alkaline phosphatase activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | 29 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 127 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBCIP
-
NoteResearch use only, not for human use.
-
Brief DescriptionBCIP (BCIP p-toluidine salt) is an artificial chromogenic substrate. It is used for the sensitive colorimetric detection of alkaline phosphatase activity.
-
DescriptionBCIP (BCIP p-toluidine salt) is an artificial chromogenic substrate. It is used for the sensitive colorimetric detection of alkaline phosphatase activity.
-
In Vitro——
-
In Vivo——
-
SynonymsBCIP p-toluidine salt | X-phosphate p-toluidine salt
-
PathwayOthers
-
TargetOther Targets
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6578-06-9
-
Formula Weight433.62
-
Molecular FormulaC15H15BrClN2O4P
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 51 mg/mL (117.61 mM)
-
SMILESCc1ccc(N)cc1.OP(O)(=O)Oc1c[nH]c2ccc(Br)c(Cl)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
(Pro34)-Neuropeptide...
[Pro34]Neuropeptide Y, porcine is a selective NPY receptor (Y1 receptor) agonist. [Pro34]Neuropeptide Y, porcine evokesvasoconstrictions in the guinea pig caval vein.
-
Cannabisin F
Melongenamides B-D and Cannabisin F have anti-inflammatory activity, they exhibit inhibitions of nitric oxide production in lipopolysaccharide-induced RAW 264.7 macrophages with IC50 values ranging from 16.2 to 58.5 uM.
-
NNMTi
NNMTi? is a substrate site-targeting, selective nicotinamide N-methyltransferase (NNMT) inhibitor (IC50 = 1.2 μM;?50 μM SAM, 100 μM NCA) that reduces 3T3-L1 lipogenesis (EC50 = 30μM) and adipocytes 1-methylnicotinamide level (EC50 = 2.3 μM) without affecting related methyltransferases & enzymes in the NAD+ salvage pathwayNNMTi treatment will rescue age-related deficits in muSC activity to promote superior regeneration post-injury in aging muscle.
